Attending the SLAS Meeting in London – December 2024

Anna Willox, PhD

Head of European Business Development

As part of Nexus BioQuest’s ongoing commitment to staying at the forefront of immunology and drug discovery, I had the opportunity to attend the SLAS (Society for Laboratory Automation and Screening) meeting in London this December. This event served as an invaluable platform for networking with industry leaders, learning about the latest advancements in laboratory automation, and exploring new technologies that could enhance our offerings at Nexus BioQuest.

Attending SLAS allowed me to connect with potential partners, discover cutting-edge developments in screening technologies, and exchange insights on best practices in drug discovery. I look forward to leveraging the knowledge and relationships gained at the event to help Nexus BioQuest continue to provide top-tier services for our clients, particularly in areas like immune profiling, cell-based assays, and immunotherapy development.

It was a fantastic experience to engage with experts and peers in the field, and I’m excited to see how the connections and insights from SLAS will help Nexus BioQuest expand its capabilities and strengthen its position in the industry. It was a true pleasure meeting so many inspiring individuals, including Sonia Houghton, Del Trezise, Jeroen Verheyen, Scott Mitchell, Dahir Ahmed, Thomas Richardson, Rob Howes, and reconnecting with familiar faces like Tom Crabbe after many years!

A huge thank you to the organizers, SLAS (Vicki Loise) and ELRIG (Sanj Kumar), as well as the sponsors, for creating such a wonderful opportunity to network and hear exciting presentations on innovations in the bioscience and drug discovery sectors, including new modalities.

I’m already looking forward to next year’s events!